decisionhealth Newsletters, Coder Pink Sheets - 2006 Issue 9 (September)
When to bill office injections with E/M and modifier 25
Subscribe or sign in to view the full article.
Article Overview
This article discusses the relationship between office evaluation and management services, injection administration, and modifier 25 in a pediatric coding context. It focuses on when a separate visit may be reported, how payer policy can affect payment, and why documentation and payer-specific guidance matter. The article also notes circumstances where a separate visit should not be reported and addresses a related testing scenario that uses a different service code.
Why This Topic Matters
Coding staff, pediatric practices, and billers need to understand when a visit and an injection can appear together on a claim and when payer policy may limit payment. The article helps readers recognize the broad documentation and policy issues involved without replacing the detailed guidance in the premium content.
Article Sections
-
Two situations when you should bill both the procedure and the visit
Introduces the main circumstances discussed for reporting an office visit together with an injection service. The section frames the article’s central distinction between separate reasons for care and follow-up care tied to an existing condition.
-
Two distinct problems
Covers a scenario involving more than one clinical issue addressed during the same encounter. The section discusses the documentation and claim reporting context for combining visit and procedure services.
-
Reevaluation for existing condition
Covers follow-up care for an ongoing condition and the related billing context. The section emphasizes the need for supporting documentation when a visit and injection occur on the same day.
-
Remember: According to both CPT and Medicare, a separate diagnosis is not necessary
Summarizes payer guidance discussed in the article from professional coding guidance and Medicare policy. The section focuses on the broader issue of same-day reporting and payer interpretation.
-
When not to bill a separate E/M with 90772
Describes a situation where a separate office visit should not be reported with the injection service. The section provides a contrast to the earlier examples and reinforces that not every injection encounter supports an additional visit code.
-
Quick Tip: 90772 not for PPD test
Notes a testing situation that uses a different service code rather than an injection administration code. The section clarifies that the article addresses both office injection reporting and a related diagnostic test scenario.
What You Will Learn
- How the article frames same-day office visit and injection reporting
- What types of encounters the article discusses in a pediatric setting
- How payer guidance and documentation affect reporting decisions
- Why some encounters may not support a separate visit charge
- How the article distinguishes office injection services from a related test scenario
Who Should Read This
- Medical coders
- Billing staff
- Pediatric practice administrators
- Revenue cycle professionals
- Compliance staff
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com